Screener
Charles River Laboratories CRL Exercised (in shares)
Exercised (in shares) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Number of shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life | Aggregate Intrinsic Value |
|---|---|---|---|---|
| Options outstanding as of December 28, 2024 | 710 | $231.19 | ||
| Options granted | 21 | $135.00 | ||
| Options exercised | (1) | $179.66 | ||
| Options canceled | (40) | $235.95 | ||
| Options outstanding as of December 27, 2025 | 690 | $228.10 | 6.22 | $6,599 |
| Options exercisable as of December 27, 2025 | 518 | $236.41 | 5.68 | $4,699 |
| Options vested and expected to vest as of December 27, 2025 | 690 | $228.10 | 6.22 | $6,599 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's exercised (in shares)?
- Charles River Laboratories (CRL) reported exercised (in shares) of $179.66 in Q4 2025.
- What does exercised (in shares) mean?
- The weighted average exercise price at which employees and directors exercised their stock options during the period. This provides insight into the historical price levels at which equity incentives were realized by participants.
Ask your AI about Charles River Laboratories's exercised (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude